Ajay Aggarwal
@AggarwalOnc
Followers
1K
Following
763
Statuses
303
Professor @LSHTM | Clinical Director National Cancer Audits | Clinical Oncologist @GSTTnhs | Cancer Services and Systems Research
London
Joined November 2018
@fabiomoraesmd highlighting the major radiotherapy research needs in the low and middle income country setting. Broad agenda from Trial capacity building, improvement and implementation science with a need to take a value based “common sense” approach. @csoncol #ASTRO24
0
4
12
RT @NATCAN_news: 💻Join us for our webinar exploring key findings from the first State of the Nation reports, covering six new national canc…
0
9
0
RT @LSHTM: UK #NHS cancer care at tipping point In @TheLancetOncol Ajay Aggarwal joins experts & clinicians calling for UK government to u…
0
4
0
RT @BreastDocUK: A new Parliament sits today If they want to think about a Cancer Plan - here's a starter for 10 @TheLancetOncol Pressu…
0
64
0
Dr Aggarwal @AggarwalOnc presenting pearls on Quality indicators: must be measurable, actionable and improvable, also emphasized indicators should be context specific. Great illustration on how QI data can drive improved outcomes. @asco #asco24 session chaired by @jrgralow
0
0
2
Excellent talk by @AggarwalOnc about UK National Prostate Cancer Audit and importance of public reporting. Great session on improving quality of cancer care globally @jrgralow @JacksonOrem #ASCO24
0
0
2
Fantastic to be involved in this collaboration with Dr Susan Msadabwe & colleagues at Cancer diseases hospital Zambia, Dorothy lombe and @DrSimwinga & colleagues at Zambart to set a country specific research agenda for prostate cancer in Zambia. @Prof_Nick_James @SullivanProf 👇
This recent study in BMJ Oncology found national priority research areas for prostate cancer in Zambia to include prostate cancer awareness and building affordable high-quality diagnostic capacity. @UnzaOfficial @AggarwalOnc
0
5
21
RT @achoud72: @AggarwalOnc tells it straight. Sobering data. Powerful stuff! Society and healthcare outcomes are intimately entwined. IT MA…
0
3
0
@drkiwicj @NBOCA_CEU @NATCAN_news Thanks Chris. The toxicity indicator doesn’t require reporting from individual clinicians. It captures G3 tox based on hosp administrative datasets. Took 3 years to develop. Let me know re: your metric. Paper with methods for hospital comparison in link
1
0
1
Fabulous fellowship opportunity for oncology or surgical trainees involved in cancer care to shape quality improvement in the management of cancer at a national and local level level across 10 cancer audits. PhD opportunity possible within role. @clinonctrainees @onctrainees 👇
Exciting opportunity!🔍 We are looking for a Quality Improvement Clinical Fellow to join the #NATCAN team. Find out more and apply 👉
0
15
21
Worth attending for those involved in prostate cancer care. Focus on improving radiotherapy quality and supporting better access to systemic therapies. Utilisation rates remain too low for men with advanced disease in the UK. 👇
Registration is open for the NPCA's free Quality Improvement event. 21st March 2024, 3.00-500pm, Online This workshop provides two CPD credits in accordance with the CPD Scheme of The Royal College of Radiologists. @RCRadiologists Go to to register
0
1
7
One in three women with breast cancer in England bypass their nearest surgical centre for treatment. Reasons not clear but our analysis shows reputation a factor rather than outcomes. How should this inform service design?👇 @abcdiagnosis @JanvanderMeule6
2
6
26
Brilliant news for the prostate cancer community. I’m sure you will excel in this important role @alison_tree @NATCAN_news
We are excited to welcome Dr Alison Tree to the National Prostate Cancer Audit as the Clinical Lead for Oncology. Alison joins us from The Royal Marsden NHS Foundation Trust where she is a Consultant clinical oncologist. You can follow Alison on @alison_tree
2
1
20
RT @Megan_Mcleod_: Our recent work in @TheLancetOncol developed a prioritized list of LMIC-specific indicators to help guide national cance…
0
3
0
The politics, power and realities of cancer drug policy. This is a must read for everyone in the oncology community and a wake up call as to the challenges to delivering affordable, equitable and high quality cancer care 👇
Power, money & cancer medicines. A reality check.
0
2
20
0
0
2
The inverse care law writ large. Low income groups in rural areas face the longest travel times by car or public transport to their nearest cancer centres. The design of our service has the capacity to perpetuate pre-existing inequalities in access.
1
13
33